efficaci safeti doxazosin treatment patient mild moder essenti hypertens elev level cholesterol hypertens patient serum cholesterol frequent sinist addit coronari risk factor select alpha inhibitor uniqu abil risk factor forty-two patient year men sustain hypertens serum cholesterol level trial monotherapi doxazosin daili rang mg influenc drug high blood pressur serum cholesterol period single-blind placebo lead-in period open dose-adjust period mainten period efficacy-evalu patient adequ blood pressur control diastol blood pressur mm Hg decreas diastol blood pressur mm Hg mean daili dose mg doxazosin persist chang heart rate patient evalu lipid data nonsignific trend increas high-dens lipoprotein cholesterol reduct total cholesterol signific reduct serum triglycerid concentr combin chang blood pressur blood lipid level reduct calcul risk coronari heart diseas eleven patient side effect therapi result antihypertens anticholesterolem efficaci once-daili treatment doxazosin 